Skip to content
OpenCapital
Get started

Veracyte VCYT Payment for Contingent Consideration Liability, Financing Activities

Payment for Contingent Consideration Liability, Financing Activities at other companies

Revvity logo
RevvityRVTY
——
IQVIA logo
IQVIAIQV
——

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.

The official record: Veracyte’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's payment for contingent consideration liability, financing activities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's payment for contingent consideration liability, financing activities?
Veracyte (VCYT) reported payment for contingent consideration liability, financing activities of $0 in Q4 2025.
How has Veracyte's payment for contingent consideration liability, financing activities changed year-over-year?
Veracyte's payment for contingent consideration liability, financing activities decreased by 100.0% year-over-year, from $1.13M to $0.